1-9 of 9
Benedikt Brors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma

Priya Chudasama, Marcus Renner, Melanie Straub, Sadaf S. Mughal, Barbara Hutter, Zeynep Kosaloglu, Ron Schweßinger, Matthias Scheffler, Ingo Alldinger, Simon Schimmack, Thorsten Persigehl, Carsten Kobe, Dirk Jäger, Christof von Kalle, Peter Schirmacher, Marie-Kristin Beckhaus, Stephan Wolf, Christoph Heining, Stefan Gröschel, Jürgen Wolf, Benedikt Brors, Wilko Weichert, Hanno Glimm, Claudia Scholl, Gunhild Mechtersheimer, Katja Specht, Stefan Fröhling
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (4): 962–973.
https://doi.org/10.1158/1078-0432.CCR-16-0860
Published: 14 February 2017
View article titled, Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma
Open the PDF for Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma in another window
Includes: Supplementary data
Journal Articles

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, Rene Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh, Robert Seeger, Miki Ohira, Akira Nakagawara, Paola Scaruffi, Gian Paolo Tonini, Isabelle Janoueix-Lerosey, Olivier Delattre, Gudrun Schleiermacher, Jo Vandesompele, Frank Speleman, Rosa Noguera, Marta Piqueras, Jean Bénard, Alexander Valent, Smadar Avigad, Isaac Yaniv, Richard G. Grundy, Monika Ortmann, Chunxuan Shao, Manfred Schwab, Roland Eils, Thorsten Simon, Jessica Theissen, Frank Berthold, Frank Westermann, Benedikt Brors, Matthias Fischer
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (8): 1904–1915.
https://doi.org/10.1158/1078-0432.CCR-14-0817
Published: 14 April 2015
View article titled, Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
Open the PDF for Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers in another window
Includes: Supplementary data
Journal Articles

High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma

Johannes H. Schulte, Hagen S. Bachmann, Bent Brockmeyer, Katleen DePreter, André Oberthür, Sandra Ackermann, Yvonne Kahlert, Kristian Pajtler, Jessica Theissen, Frank Westermann, Jo Vandesompele, Frank Speleman, Frank Berthold, Angelika Eggert, Benedikt Brors, Barbara Hero, Alexander Schramm, Matthias Fischer
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5082–5092.
https://doi.org/10.1158/1078-0432.CCR-10-2809
Published: 31 July 2011
View article titled, High <em>ALK</em> Receptor Tyrosine Kinase Expression Supersedes <em>ALK</em> Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
Open the PDF for High <em>ALK</em> Receptor Tyrosine Kinase Expression Supersedes <em>ALK</em> Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

Katleen De Preter, Joëlle Vermeulen, Benedikt Brors, Olivier Delattre, Angelika Eggert, Matthias Fischer, Isabelle Janoueix-Lerosey, Cinzia Lavarino, John M. Maris, Jaume Mora, Akira Nakagawara, André Oberthuer, Miki Ohira, Gudrun Schleiermacher, Alexander Schramm, Johannes H. Schulte, Qun Wang, Frank Westermann, Frank Speleman, Jo Vandesompele
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (5): 1532–1541.
https://doi.org/10.1158/1078-0432.CCR-09-2607
Published: 28 February 2010
View article titled, Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
Open the PDF for Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature in another window
Includes: Supplementary data
Journal Articles

Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR

André Oberthuer, Lars Kaderali, Yvonne Kahlert, Barbara Hero, Frank Westermann, Frank Berthold, Benedikt Brors, Roland Eils, Matthias Fischer
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6590–6601.
https://doi.org/10.1158/1078-0432.CCR-07-4377
Published: 16 October 2008
View article titled, Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR
Open the PDF for Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR in another window
Includes: Supplementary data
Journal Articles

High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status

Frank Westermann, Kai-Oliver Henrich, Jun S. Wei, Werner Lutz, Matthias Fischer, Rainer König, Ruprecht Wiedemeyer, Volker Ehemann, Benedikt Brors, Karen Ernestus, Ivo Leuschner, Axel Benner, Javed Khan, Manfred Schwab
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (16): 4695–4703.
https://doi.org/10.1158/1078-0432.CCR-06-2818
Published: 15 August 2007
View article titled, High <em>Skp2</em> Expression Characterizes High-Risk Neuroblastomas Independent of <em>MYCN</em> Status
Open the PDF for High <em>Skp2</em> Expression Characterizes High-Risk Neuroblastomas Independent of <em>MYCN</em> Status in another window
Includes: Supplementary data
Journal Articles

Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome

Alexander Schramm, Jo Vandesompele, Johannes H. Schulte, Sabine Dreesmann, Lars Kaderali, Benedikt Brors, Roland Eils, Frank Speleman, Angelika Eggert
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (5): 1459–1465.
https://doi.org/10.1158/1078-0432.CCR-06-2032
Published: 01 March 2007
View article titled, Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome
Open the PDF for Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome in another window
Journal Articles

Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome

Matthias Fischer, André Oberthuer, Benedikt Brors, Yvonne Kahlert, Matthias Skowron, Harald Voth, Patrick Warnat, Karen Ernestus, Barbara Hero, Frank Berthold
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (17): 5118–5128.
https://doi.org/10.1158/1078-0432.CCR-06-0985
Published: 01 September 2006
View article titled, Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome
Open the PDF for Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome in another window
Includes: Supplementary data
Journal Articles

Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients

Kai-Oliver Henrich, Matthias Fischer, Daniel Mertens, Axel Benner, Ruprecht Wiedemeyer, Benedikt Brors, André Oberthuer, Frank Berthold, Jun Stephen Wei, Javed Khan, Manfred Schwab, Frank Westermann
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 131–138.
https://doi.org/10.1158/1078-0432.CCR-05-1431
Published: 05 January 2006
View article titled, Reduced Expression of <em>CAMTA1</em> Correlates with Adverse Outcome in Neuroblastoma Patients
Open the PDF for Reduced Expression of <em>CAMTA1</em> Correlates with Adverse Outcome in Neuroblastoma Patients in another window